11703

539523

ALKEM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ALKEM LABORATORIES LTD. Share Price Today

ALKEM LABORATORIES LTD. is currently trading at ₹5462, up by ₹46.5 from the previous close. The stock touched an intraday high of ₹5490.50 and a low of ₹5431.50 during the latest trading session. Over the past one year, ALKEM LABORATORIES LTD. has delivered a return of 12.75%, while the stock has declined 0.69% in the last one month.

ALKEM LABORATORIES LTD. performance

Today’s low Today’s high
₹ 5431.50 ₹ 5490.50
₹ 5459.00
52 week low 52 week high
₹ 4716.20 ₹ 5933.50
₹ 5459.00
Open Price ₹ 5460.00
Prev. Close ₹ 5415.50
Volume (Shares) 31248.00
Total traded value ₹ 1705.82
Upper Circuit ₹ 5957.00
Lower Circuit ₹ 4874.00
info

Investment Returns

Over 1 Month -0.69% Over 3 Months 4.32% Over 6 Months -4.56% Over 1 Year 12.75%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ALKEM LABORATORIES LTD. fundamentals


  • Market cap (Cr) 65,276.50
  • P/E Ratio (TTM) 28.35
  • Beta 0.72
  • Book Value / share 1,170.80
  • Return on equity 19.94%
  • EPS (TTM) 192.67
  • Dividend yield 0.98%
  • Net profit/quarter (Cr) 217.06
info icon alternate text
  • Market cap (Cr) 65,319.60
  • P/E Ratio (TTM) 28.35
  • Beta 0.67
  • Book Value / share 1,170.80
  • Return on equity 19.94%
  • EPS (TTM) 192.67
  • Dividend yield 0.98%
  • Net profit/quarter (Cr) 217.06
info icon alternate text

ALKEM LABORATORIES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 2258.44
Operating Expense 2008.83
Net Profit 217.06
Net Profit Margin (%) 9.61
Earnings Per Share (EPS) 18.16
EBITDA 430.50
Effective Tax Rate (%) 35.41
Particulars DEC 2025 (Values in Cr)
Revenue 2491.27
Operating Expense 1878.48
Net Profit 622.14
Net Profit Margin (%) 24.97
Earnings Per Share (EPS) 52.03
EBITDA 782.56
Effective Tax Rate (%) 11.89
Particulars SEP 2025 (Values in Cr)
Revenue 2542.03
Operating Expense 1842.69
Net Profit 786.73
Net Profit Margin (%) 30.94
Earnings Per Share (EPS) 65.80
EBITDA 872.05
Effective Tax Rate (%) 9.62
Particulars JUN 2025 (Values in Cr)
Revenue 2372.17
Operating Expense 1823.37
Net Profit 656.16
Net Profit Margin (%) 27.66
Earnings Per Share (EPS) 54.88
EBITDA 751.34
Effective Tax Rate (%) 8.44
Particulars MAR 2025 (Values in Cr)
Revenue 2044.94
Operating Expense 1856.70
Net Profit 276.94
Net Profit Margin (%) 13.54
Earnings Per Share (EPS) 23.17
EBITDA 408.38
Effective Tax Rate (%) 24.66
Particulars MAR 2026 (Values in Cr)
Revenue 9663.91
Operating Expense 7553.37
Net Profit 2282.09
Net Profit Margin (%) 23.61
Earnings Per Share (EPS) 182.76
EBITDA 2836.47
Effective Tax Rate (%) 13.37
Particulars MAR 2025 (Values in Cr)
Revenue 8813.44
Operating Expense 7016.96
Net Profit 2280.89
Net Profit Margin (%) 25.87
Earnings Per Share (EPS) 190.77
EBITDA 2663.26
Effective Tax Rate (%) 9.28
Particulars MAR 2024 (Values in Cr)
Revenue 7963.85
Operating Expense 6611.88
Net Profit 1747.15
Net Profit Margin (%) 21.93
Earnings Per Share (EPS) 146.13
EBITDA 1913.34
Effective Tax Rate (%) 2.10
Particulars MAR 2023 (Values in Cr)
Revenue 9054.55
Operating Expense 7993.84
Net Profit 1134.47
Net Profit Margin (%) 12.52
Earnings Per Share (EPS) 94.88
EBITDA 1643.24
Effective Tax Rate (%) 14.50
Particulars MAR 2022 (Values in Cr)
Revenue 8829.81
Operating Expense 7276.33
Net Profit 1541.25
Net Profit Margin (%) 17.45
Earnings Per Share (EPS) 128.90
EBITDA 2010.25
Effective Tax Rate (%) 12.09
Particulars MAR 2025 (Values in Cr)
Book Value / Share 1002.50
ROE % 19.88
ROCE % 20.03
Total Debt to Total Equity 0.13
EBITDA Margin 23.19
Particulars MAR 2024 (Values in Cr)
Book Value / Share 862.57
ROE % 18.72
ROCE % 18.29
Total Debt to Total Equity 0.15
EBITDA Margin 19.22
Particulars MAR 2023 (Values in Cr)
Book Value / Share 756.61
ROE % 11.39
ROCE % 12.48
Total Debt to Total Equity 0.23
EBITDA Margin 14.85
Particulars MAR 2022 (Values in Cr)
Book Value / Share 722.53
ROE % 20.98
ROCE % 18.02
Total Debt to Total Equity 0.27
EBITDA Margin 20.69
Particulars MAR 2021 (Values in Cr)
Book Value / Share 617.04
ROE % 23.90
ROCE % 21.72
Total Debt to Total Equity 0.25
EBITDA Margin 24.54
Particulars MAR 2025 (Values in Cr)
Book Value / Share 1030.68
ROE % 19.94
ROCE % 20.29
Total Debt to Total Equity 0.06
EBITDA Margin 32.32
Particulars MAR 2024 (Values in Cr)
Book Value / Share 882.86
ROE % 17.56
ROCE % 16.38
Total Debt to Total Equity 0.11
EBITDA Margin 26.34
Particulars MAR 2023 (Values in Cr)
Book Value / Share 782.09
ROE % 12.54
ROCE % 12.78
Total Debt to Total Equity 0.19
EBITDA Margin 18.15
Particulars MAR 2022 (Values in Cr)
Book Value / Share 731.38
ROE % 18.83
ROCE % 17.47
Total Debt to Total Equity 0.22
EBITDA Margin 22.77
Particulars MAR 2021 (Values in Cr)
Book Value / Share 637.87
ROE % 24.23
ROCE % 22.76
Total Debt to Total Equity 0.19
EBITDA Margin 29.45
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1563.08
Total Assets 17691.10
Total Liabilities 17691.10
Total Equity 12433.63
Share Outstanding 11
Price to Book Ratio 4.73
Return on Assets (%) 12.24
Return on Capital (%) 16.04
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1579.35
Total Assets 15574.90
Total Liabilities 15574.90
Total Equity 10714.40
Share Outstanding 11
Price to Book Ratio 5.60
Return on Assets (%) 11.52
Return on Capital (%) 15.05
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2616.89
Total Assets 13756.65
Total Liabilities 13756.65
Total Equity 9435.00
Share Outstanding 11
Price to Book Ratio 4.34
Return on Assets (%) 7.15
Return on Capital (%) 9.16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2578.58
Total Assets 14069.19
Total Liabilities 14069.19
Total Equity 8847.33
Share Outstanding 11
Price to Book Ratio 4.95
Return on Assets (%) 11.69
Return on Capital (%) 14.4
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1990.45
Total Assets 11519.26
Total Liabilities 11519.26
Total Equity 7558.01
Share Outstanding 11
Price to Book Ratio 4.35
Return on Assets (%) 13.75
Return on Capital (%) 17.18
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1056.11
Total Assets 15595.60
Total Liabilities 15595.60
Total Equity 12321.83
Share Outstanding 11
Price to Book Ratio 4.73
Return on Assets (%) 14.62
Return on Capital (%) 17.97
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1065.85
Total Assets 14037.80
Total Liabilities 14037.80
Total Equity 10554.61
Share Outstanding 11
Price to Book Ratio 5.60
Return on Assets (%) 12.44
Return on Capital (%) 15.18
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2163.87
Total Assets 12731.22
Total Liabilities 12731.22
Total Equity 9349.85
Share Outstanding 11
Price to Book Ratio 4.34
Return on Assets (%) 8.91
Return on Capital (%) 10.83
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2297.21
Total Assets 13169.17
Total Liabilities 13169.17
Total Equity 8743.66
Share Outstanding 11
Price to Book Ratio 4.95
Return on Assets (%) 11.70
Return on Capital (%) 14.03
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1673.36
Total Assets 10772.73
Total Liabilities 10772.73
Total Equity 7625.75
Share Outstanding 11
Price to Book Ratio 4.35
Return on Assets (%) 15.64
Return on Capital (%) 18.8
Particulars MAR 2025 (Values in Cr)
Net Income 2527.03
Cash from Operations 2416.86
Cash from Investing -1298.76
Cash from Financing -810.99
Net change in Cash -196.91
Free Cash Flow 3092.48
Particulars MAR 2024 (Values in Cr)
Net Income 2023.13
Cash from Operations 2355.01
Cash from Investing -1008.50
Cash from Financing -1145.01
Net change in Cash -205.44
Free Cash Flow 2614.30
Particulars MAR 2023 (Values in Cr)
Net Income 1304.77
Cash from Operations 1955.89
Cash from Investing 112.84
Cash from Financing -1760.82
Net change in Cash 34.52
Free Cash Flow 2188.80
Particulars MAR 2022 (Values in Cr)
Net Income 1844.28
Cash from Operations 1507.92
Cash from Investing -1435.13
Cash from Financing 379.57
Net change in Cash 55.46
Free Cash Flow 1846.80
Particulars MAR 2021 (Values in Cr)
Net Income 1842.10
Cash from Operations 1665.58
Cash from Investing -998.54
Cash from Financing -271.75
Net change in Cash -5.39
Free Cash Flow 1860.49
Particulars MAR 2025 (Values in Cr)
Net Income 2597.39
Cash from Operations 2586.04
Cash from Investing -1007.41
Cash from Financing -1036.89
Net change in Cash 145.11
Free Cash Flow 2812.24
Particulars MAR 2024 (Values in Cr)
Net Income 1881.03
Cash from Operations 2039.39
Cash from Investing -865.60
Cash from Financing -959.04
Net change in Cash -138.08
Free Cash Flow 2146.07
Particulars MAR 2023 (Values in Cr)
Net Income 1326.99
Cash from Operations 1661.58
Cash from Investing 197.04
Cash from Financing -1711.27
Net change in Cash -76.81
Free Cash Flow 1803.36
Particulars MAR 2022 (Values in Cr)
Net Income 1753.37
Cash from Operations 1634.19
Cash from Investing -1669.33
Cash from Financing 436.59
Net change in Cash 66.60
Free Cash Flow 1879.06
Particulars MAR 2021 (Values in Cr)
Net Income 1884.30
Cash from Operations 1645.78
Cash from Investing -1120.99
Cash from Financing -208.96
Net change in Cash -5.47
Free Cash Flow 1776.59
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.60 13.06 1.52 242.16 23.12 38.85
BLISS GVS PHARMA LTD. 473.30 38.42 4.20 5019.64 118.35 493.70
CIPLA LTD 1415.30 30.04 3.32 114334.35 1165.55 1672.20
FERMENTA BIOTECH LTD. 341.80 15.08 2.47 1005.95 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.60 22.10 4.07 242.16 23.12 38.85
AMRUTAJAN HEALTH LTD 546.80 24.51 4.26 1580.83 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8556.55 111.75 24.50 21391.38 7630.00 9850.00
BLISS GVS PHARMA LTD. 473.30 51.06 4.34 5019.64 118.35 493.70

ALKEM LABORATORIES LTD. shareholding pattern

Holding
17.24%
51.19%
10.15%
21.39%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

ALKEM LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
5459.50 0.81 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 5377.70
  • 26 Days 5371.90
  • 10 Days 5361.70
  • 50 Days 5400.10
  • 12 Days 5359.90
  • 100 Days 5437.90
  • 20 Days 5364.60
  • 200 Days 5443.60
5367.00 PIVOT
First Support 5336.00 First Resistance 5398.00 Second Support 5305.00 Second Resistance 5429.00 Third Support 5274.00 Third Resistance 5460.00
RSI 49.71 ADX 23.31 MACD -18.58 Williams % R -33.50 Commodity Channel Index (CCI) 21.45
Date 2026-06-22 Week 45401.00 Same Day 55515.00 Month 84668.00
1 Year 0.74 3 Year 0.64
Over 1 Month
-0.69% down
Over 1 Year
12.75% down
Over 3 Months
4.32% down
Over 3 Years
17.01% down
Over 6 Months
-4.56% down
Over 5 Years
11.24% down

ALKEM LABORATORIES LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
20 Feb 2026 43.0 Interim 20 Feb 2026 Equity shares
08 Aug 2025 8.0 Final 08 Aug 2025 Equity shares
14 Feb 2025 37.0 Interim 14 Feb 2025 Equity shares
09 Aug 2024 5.0 Final 10 Aug 2024 Equity shares
16 Feb 2024 35.0 Interim 17 Feb 2024 Equity shares
10 Aug 2023 10.0 Final 10 Aug 2023 Equity shares
17 Feb 2023 25.0 Special 18 Feb 2023 Equity shares
17 Feb 2023 15.0 Interim 18 Feb 2023 Equity shares
08 Aug 2022 4.0 Final 10 Aug 2022 Equity shares
10 Feb 2022 30.0 Interim 12 Feb 2022 Equity shares
09 Aug 2021 5.0 Final 10 Aug 2021 Equity shares
11 Feb 2021 25.0 Interim 13 Feb 2021 Equity shares
10 Aug 2020 3.0 Final 11 Aug 2020 Equity shares
13 Feb 2020 22.0 Interim 15 Feb 2020 Equity shares
19 Aug 2019 8.0 Final 20 Aug 2019 Equity shares
15 Feb 2019 8.0 Interim 18 Feb 2019 Equity shares
23 Aug 2018 7.0 Final 24 Aug 2018 Equity shares
16 Feb 2018 6.0 Interim 20 Feb 2018 Equity shares
31 Aug 2017 9.0 Final 01 Sep 2017 Equity shares
23 Nov 2016 6.0 Interim 24 Nov 2016 Equity shares
18 Mar 2016 9.7 Interim 2 21 Mar 2016 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
20 Feb 2026 43.0 Interim 20 Feb 2026 Equity shares
08 Aug 2025 8.0 Final 08 Aug 2025 Equity shares
14 Feb 2025 37.0 Interim 14 Feb 2025 Equity shares
09 Aug 2024 5.0 Final 10 Aug 2024 Equity shares
16 Feb 2024 35.0 Interim 17 Feb 2024 Equity shares
10 Aug 2023 10.0 Final 10 Aug 2023 Equity shares
17 Feb 2023 25.0 Special 18 Feb 2023 Equity shares
17 Feb 2023 15.0 Interim 18 Feb 2023 Equity shares
08 Aug 2022 4.0 Final 10 Aug 2022 Equity shares
10 Feb 2022 30.0 Interim 12 Feb 2022 Equity shares
09 Aug 2021 5.0 Final 10 Aug 2021 Equity shares
11 Feb 2021 25.0 Interim 13 Feb 2021 Equity shares
10 Aug 2020 3.0 Final 11 Aug 2020 Equity shares
13 Feb 2020 22.0 Interim 15 Feb 2020 Equity shares
19 Aug 2019 8.0 Final 20 Aug 2019 Equity shares
15 Feb 2019 8.0 Interim 18 Feb 2019 Equity shares
23 Aug 2018 7.0 Final 24 Aug 2018 Equity shares
16 Feb 2018 6.0 Interim 20 Feb 2018 Equity shares
31 Aug 2017 9.0 Final 01 Sep 2017 Equity shares
23 Nov 2016 6.0 Interim 24 Nov 2016 Equity shares
18 Mar 2016 9.7 Interim 2 21 Mar 2016 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Alkem Laboratories Ltd?

Answer Field

Alkem Laboratories Ltd share price is for NSE ₹ 5,462.00 & for BSE ₹ 5,465.00 as on Jun 24 2026 11:10 AM.

What is the Market Cap of Alkem Laboratories Ltd Share?

Answer Field

The market cap of Alkem Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 24 2026 11:10 AM.

What is the 52 Week High and Low of Alkem Laboratories Ltd?

Answer Field

The 52 Week High and Low of Alkem Laboratories Ltd for NSE is ₹ 5,933.50 and ₹ 4,716.20 and for BSE is ₹ 5,933.00 and ₹ 4,716.75.

What is 1 year return for Alkem Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 13.77%.

What is the P/E Ratio of Alkem Laboratories Ltd Share?

Answer Field

As on Jun 24 2026 11:10 AM the price-to-earnings (PE) ratio for Alkem Laboratories Ltd share is 28.35.

What is the PB ratio of Alkem Laboratories Ltd Share?

Answer Field

As on Jun 24 2026 11:10 AM, the price-to-book (PB) ratio for Alkem Laboratories Ltd share is 1170.80.

How to Buy Alkem Laboratories Ltd Share?

Answer Field

You can trade in Alkem Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Alkem Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Alkem Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Alkem Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|